logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Cenexel Clinical Research Acquires Rocky Mountain Movement Disorders Center

Jan 11, 2022•almost 4 years ago

Acquiring Company

CenExel Clinical Research

Acquired Company

Rocky Mountain Movement Disorders Center

Salt Lake CityHealth Care

Description

CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of Rocky Mountain Movement Disorders Center’s clinical research site operations. CenExel Rocky Mountain Clinical Research (“CenExel RMCR”) is a leading movement disorders-focused research facility in Denver, with experience spanning more than 100 clinical trial studies. The primary indications served by CenExel RMCR include Parkinson’s Disease, Huntington’s Disease, Essential Tremor, and other movement disorders.

Company Information

Company

CenExel Clinical Research

Location

Salt Lake City, Utah, United States

About

CenExel Clinical Research (www.CenExel.com) provides unparalleled medical and scientific support in the design and execution of clinical trials. Our therapeutic area focus and attention to detail assures quality, reliable results and has helped CenExel to consistently achieve and exceed patient recruitment goals. CenExel Centers of Excellence have conducted thousands of studies, the variety and complexity of which have resulted in a vast depth of experience and insight for the Principal Investigators and research staff in each facility. The CenExel Centers of Excellence deliver the engagement, expertise, and results to ensure that their clients achieve their clinical research goals.

Related People

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed